Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ASTEX PHARMACEUTICALS, INC.

Home Clinical Trial Sponsors and OrganizationsASTEX PHARMACEUTICALS, INC.

ASTEX PHARMACEUTICALS, INC.

ACTIVE

10 Cattleya Ct, 加利福尼亚州阿拉梅达县, California, United Stateswww.astx.comSubsidiary136 employeesEstablished: 2011-01-01

Part of OTSUKA PHARMACEUTICAL CO., LTD.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

104

53 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2011

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

71

68.3%

Phase 2

16

15.4%

Phase 3

9

8.7%

Not Applicable

1

1.0%

Trial Status Distribution

Active, not recruiting

52

50.0%

Completed

36

34.6%

Not yet recruiting

1

1.0%

Terminated

9

8.7%

Unknown

5

4.8%

Withdrawn

1

1.0%

Clinical Trials

Trials sponsored by this organization (104)

A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)

Jun 20232 participants

Clinical study to find out how safe is ASTX295 (study drug) and how ASTX295 affects the body in patients with advanced solid tumors with normal TP53 gene

Active, not recruiting

Jul 2022186 participants

Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 with a Food Effect Substudy

Active, not recruiting

Dec 2021300 participants

Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727

Active, not recruiting

Aug 2021300 participants

A Phase 1-2 Study of the Safety and Activity of ASTX029 in Patients with Advanced Solid Tumors

Active, not recruiting

Aug 2021300 participants

Thorough QT Assessment of Cedazuridine in Healthy Subjects

Jul 202136 participants

A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects with Lower Risk (IPSS Low or Intermediate-1) Myelodysplastic Syndromes (MDS)

Active, not recruiting

Jun 2021168 participants

A Phase 1-2 Study of the Safety and Activity of ASTX029 in Patients with Advanced Solid Tumors

Active, not recruiting

Jan 2021300 participants

Page 1 of 13

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials104
Approvals
News

Back to Organizations